ANAB earnings date and last-quarter result: last quarter beat, P/E -61.89. Updated 2026-07-23.
AnaptysBio (ANAB) Research Hub
AnaptysBio (ANAB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 48.77 USD (+0.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -61.89, market cap 2.26B. This hub links to the full technical, earnings and options research available for ANAB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 48.77 USD (+0.08%) |
| 52-week range | 44.02 USD – 70.41 USD |
| Trend regime | Range |
| 14-day RSI | 52.4 (Neutral) |
| Trailing P/E | -61.89 |
| Market cap | 2.26B |
| Dividend yield | 0.00% |
Available research for ANAB
Covered Call on ANAB: how it works, illustrative setup around the real 48.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ANAB: how it works, illustrative setup around the real 48.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ANAB: how it works, illustrative setup around the real 48.77 USD price, max profit/loss, breakeven and when to use it. Educational.
ANAB technical analysis: range, last 48.77 USD, RSI 52.4, 52w range 44.02 USD–70.41 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ANAB in?
AnaptysBio (ANAB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ANAB in an uptrend or downtrend?
As of 2026-10-26, ANAB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ANAB's trailing P/E ratio?
ANAB's trailing P/E is -61.89, with a market cap of 2.26B. See the earnings research page for full valuation detail.